Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT (Details Narrative)

v3.10.0.1
SHAREHOLDERS' DEFICIT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 10 Months Ended
Jun. 12, 2018
Mar. 07, 2018
Jan. 02, 2018
Jun. 30, 2018
Apr. 30, 2018
Apr. 25, 2018
Mar. 28, 2018
Jan. 22, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 27, 2016
Dec. 31, 2017
Common shares issued for debt conversion, Shares             136,894              
Common shares issued for debt conversion, Amount             $ 100,000              
Share Price                           $ 0.85
Stock-based compensation                     $ 2,503,788 $ 1,207,016    
Accrued interest             $ 5,833              
Stock-based professional fees                     70,417 0    
Prepaid expenses       $ 18,333         $ 18,333   $ 18,333      
Exercise of stock options, Shares                     1,293,492      
Exercise of stock options, Value                     $ 40,000 0    
Stock options per share                     $ 0.031      
Research and development expense                 $ 51,345 $ 22,112 $ 68,605 105,389    
Increase decrease in accounts payable                     119,997 55,379    
Increase decrease in accrued expenses                     2,201 (5,745)    
Common share exercise compensation, Shares                         750,000  
Common share exercise compensation periodic payment                         $ 5,000  
Option exercise price                         $ 1.00  
Options exercise                     145,000 115,000    
Compensation expense                     30,000 $ 30,000    
Former Chief Executive Officer [Member]                            
Common shares issued for debt conversion, Shares     12,694,893                      
Common shares issued for debt conversion, Amount     $ 392,558                      
Share Price     $ 0.021                      
Stock-based compensation     $ 270,878                      
Vendor                            
Common shares issued for settlement, Shares         315,957                  
Common shares issued for settlement, Value         $ 268,694                  
Research and development expense         153,779                  
Increase decrease in accounts payable         39,915                  
Increase decrease in accrued expenses         $ 75,000                  
Investor                            
Sale of common shares, Shares         32,337                  
Sale of common shares, Value         $ 27,500                  
Employees | Restricted Stock [Member]                            
Share Price         $ 0.85                  
Stock-based compensation                     $ 389,583      
Issuance of common shares for services, Shares         3,233,732                  
Issuance of common shares for services, Amount         $ 2,750,000                  
Non-vested shares forfeited       485,060                    
Vesting period         1 year                  
Subscription Agreement | Six accredited investor                            
Common stock issued for merger, Shares         3,100,000                  
Common stock issued for merger, Value         $ 1,240,000                  
Consulting Agreement                            
Share Price $ 0.40 $ 0.85                        
Issuance of common shares for services, Shares 50,000 80,843                        
Issuance of common shares for services, Amount $ 20,000 $ 68,750                        
Securities purchase agreement | Esousa | Senior secured convertible note                            
Warrants issued               293,123            
Term               5 years            
Purchase price per unit               $ 0.87            
C-Bond Systems, LLC                            
Deemed issuance of common stock for reverse recapitalization, Shares           9,106,250                
Deemed issuance of common stock for reverse recapitalization, Value           $ 187,401                
2018 Long-term Incentive Plan                            
Vesting period                     1 year      
Aggregate number of common stock issued under plan                     50,000,000      
Maximum number of common stock available in incentive stock options       50,000,000         50,000,000   50,000,000